NYSE:JNJ

Johnson & Johnson Stock Insider Trading

Healthcare > Drug Manufacturers - General

Buy JNJ

*Your capital is at risk

$231.29

+2.90 (+1.27%)

At Close: Jun 22, 2026

Johnson & Johnson Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -61.62. In total, the insiders bought 558.8M and sold 216.14K JNJ shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-61.62
● Buy	558.8M shares
● Sell	216.14K shares
71% Buy Activity Strong Negative Correlation
Sell Signal High Confidence Feb 17, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -61.62. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 11, 2026 Sell	Common Stock S-Sale	Wengel Kathryn E EVP, Chief To And Risk Officer	Officer	10 000 Value: $2.41M
Jun 11, 2026 Buy	Employee Stock Options (Right to Buy) M-Exempt	Wengel Kathryn E EVP, Chief To And Risk Officer	Officer	10 000 Value: $1.16M
Jun 11, 2026 Buy	Common Stock M-Exempt	Wengel Kathryn E EVP, Chief To And Risk Officer	Officer	10 000 Value: $1.16M
Jun 09, 2026 Buy	Deferred Share Units A-Award	Woods Eugene A. Director	Director	161 Value: $38.2K
Jun 09, 2026 Buy	Deferred Share Units A-Award	Hewson Marillyn A Director	Director	215 Value: $50.9K
Jun 09, 2026 Buy	Deferred Share Units A-Award	Pinto Daniel E Director	Director	134 Value: $31.8K
May 01, 2026 Sell	Common Stock F-InKind	Reed John C EVP, Innovative Medicine, R&d	Officer	11 002 Value: $2.53M
May 01, 2026 Buy	Restricted Share Units M-Exempt	Reed John C EVP, Innovative Medicine, R&d	Officer	25 255 Value: $5.74M
May 01, 2026 Buy	Common Stock M-Exempt	Reed John C EVP, Innovative Medicine, R&d	Officer	25 255 Value: $5.74M
Apr 23, 2026 Buy	Deferred Share Units A-Award	Weinberger Mark A Director	Director	975 Value: $224.9K
Apr 23, 2026 Buy	Deferred Share Units A-Award	Pinto Daniel E Director	Director	1 712 Value: $394.9K
Apr 23, 2026 Buy	Deferred Share Units A-Award	Mcclellan Mark B. Director	Director	975 Value: $224.9K
Apr 23, 2026 Buy	Deferred Share Units A-Award	Hewson Marillyn A Director	Director	975 Value: $224.9K
Apr 23, 2026 Buy	Deferred Share Units A-Award	Beckerle Mary C Director	Director	975 Value: $224.9K
Apr 23, 2026 Buy	Deferred Share Units A-Award	Doudna Jennifer A Director	Director	975 Value: $224.9K
Apr 23, 2026 Buy	Deferred Share Units A-Award	Johnson Paula A Director	Director	975 Value: $224.9K
Apr 23, 2026 Buy	Deferred Share Units A-Award	Joly Hubert Director	Director	975 Value: $224.9K
Apr 23, 2026 Buy	Deferred Share Units A-Award	Morikis John G Director	Director	1 540 Value: $355.2K
Apr 23, 2026 Buy	Deferred Share Units A-Award	West Nadja Director	Director	975 Value: $224.9K
Apr 23, 2026 Buy	Deferred Share Units A-Award	Woods Eugene A. Director	Director	975 Value: $224.9K
Mar 10, 2026 Buy	Deferred Share Units A-Award	Hewson Marillyn A Director	Director	206 Value: $50.3K
Mar 10, 2026 Buy	Deferred Share Units A-Award	Pinto Daniel E Director	Director	129 Value: $31.5K
Mar 10, 2026 Buy	Deferred Share Units A-Award	Woods Eugene A. Director	Director	155 Value: $37.7K
Feb 27, 2026 Buy	Employee Stock Options (Right to Buy) M-Exempt	Decker Robert J Vp Corporate Controller	Officer	4 075 Value: $471.4K
Feb 27, 2026 Sell	Common Stock S-Sale	Decker Robert J Vp Corporate Controller	Officer	4 075 Value: $1.01M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT JOHNSON & JOHNSON

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED co...

Read Full Profile Here